Exhaled Breath Marker in Asthma Patients with Gastroesophageal Reflux Disease
Exhaled Breath Marker in Asthma Patients with Gastroesophageal Reflux Disease
复制标题
哮喘合并胃食管反流病患者的呼出气标记物
DOI:
--
复制
发表时间:
2007
影响因子:
2.4
通讯作者:
M. Mori
中科院分区:
文献类型:
--
作者:
Y. Shimizu;K. Dobashi;M. Mori
Prevention of acid is important in gastroesophageal reflex disease (GERD)-related asthma therapy. Proton pump inhibitors (PPI) and H2-receptor blockers have been reported as useful therapies for improving asthma symptoms. GERD prevalence is high in asthma; however, methods for validating GERD existence based on questionnaire, endoscopic examination and 24h-pH monitoring do not directly determine GERD influence on the airway. Exhaled breath condensate analysis is a novel and non-invasive tool for assessing information directly from the airway. Breath collected by cooling can be applied to pH, 8-isoprostane and cytokine analysis in patients with GERD-related asthma, and the pH and 8-isoprostane levels have been shown to reflect the effects of PPI therapy in these patients. Although the analysis of cooled breath has not yet been established in a clinical setting, this method is expected to provide a novel tool for monitoring airway acidification associated with GERD.